Another group showed that H19 induced the aggressive phenotype of endometrial cancer by targeting miR-20b-5p/AXL/HIF-1α signaling, providing a further target for treating endometrial cancer (Fig. 4B) 127. This evidence concerns the gene HIF1A and endometrial cancer.